Avelumab (anti-PD-L1) in platinum-resistant/refractory ovarian cancer: JAVELIN Ovarian 200 Phase III study design

Eric Pujade-Lauraine, Keiichi Fujiwara, Samuel S Dychter, Geeta Devgan, Bradley J Monk
  • Future Oncology, September 2018, Future Medicine
  • DOI: 10.2217/fon-2018-0070

The authors haven't yet claimed this publication.

Read Publication

http://dx.doi.org/10.2217/fon-2018-0070

In partnership with: